Mirae Asset Capital Life Science, Inc.
Emerging managerSEC exempt reporting adviser (private fund adviser exemption, under $150M).
- HQ
- MA
Mirae Asset Capital Life Science is a life science investment firm. Its team includes Thomas Suter, PhD, an Associate, and David T. Paik, PhD, a Vice President. One of its portfolio companies is Attovia, which is developing biotherapeutics for immune-mediated diseases using its proprietary ATTOBODY platform to create bispecific and multispecific treatments.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Healthtech, Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Mirae Asset BioHealth Ingenuity Fund I, LP Mirae Asset Capital Life Science invests in life science companies, mainly Series A and B stage businesses entering the clinic. It focuses on oncology, immunology, CV/metabolic, CNS/ophthalmology, and rare genetic disease, prioritizing small molecules, biologics, and nucleic acid therapeutics. Inferred from the firm's website | 2026 | $5.37M (Form D) | Open, writing first checks |
| Mirae Asset Capital Life Science Inception I, LP Mirae Asset Capital Life Science invests in life science companies, mainly Series A and B stage businesses entering the clinic. It focuses on oncology, immunology, CV/metabolic, CNS/ophthalmology, and rare genetic disease, prioritizing small molecules, biologics, and nucleic acid therapeutics. Inferred from the firm's website | 2023 | $51M (Form D) | Open, writing first checks |
03 · People across funds
- Young Hwan Kim, President of the Manager of the General Partner of the Issuer.
Mirae Asset BioHealth Ingenuity Fund I, LP (Named on Form D); Mirae Asset Capital Life Science Inception I, LP (Named on Form D)
- David T. Paik, PhD, Vice President
Mirae Asset BioHealth Ingenuity Fund I, LP (Team); Mirae Asset Capital Life Science Inception I, LP (Team)
- Thomas Suter, PhD, Associate
Mirae Asset BioHealth Ingenuity Fund I, LP (Team); Mirae Asset Capital Life Science Inception I, LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.lifesci.miraeasset.com
- https://www.lifesci.miraeasset.com/contact
- https://www.lifesci.miraeasset.com/portfolio
- https://www.lifesci.miraeasset.com/team
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026